Positive data from vibegron long-term extension study announced

Results from the 40-week extension of the EMPOWUR study show results consistent with the main 12-week study, with 61% having a ≥75% reduction in urge urinary incontinence and 71.1% having a ≥50% reduction in total incontinence episodes from baseline to week 52 [no absolute data].

Source:

Biospace Inc.